Performance in population models for count data, part II: a new SAEM algorithm

Por Savic, Radojka, Lavielle, Marc
Publicado em 2009

Evaluation of an Extended Grid Method for Estimation Using Nonparametric Distributions

Por Savic, Radojka M., Karlsson, Mats O.
Publicado em 2009

Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions

Por Savic, Radojka M., Karlsson, Mats O.
Publicado em 2009

Implementation and Evaluation of the SAEM Algorithm for Longitudinal Ordered Categorical Data with an Illustration in Pharmacokinetics–Pharmacodynamics

Por Savic, Radojka M., Mentré, France, Lavielle, Marc
Publicado em 2010

Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis

Por Savic, Radojka M., Novakovic, Ana M., Ekblom, Marianne, Munafo, Alain, Karlsson, Mats O.
Publicado no Clin Pharmacokinet (2017)

Application of population pharmacokinetics to cladribine

Por Lindemalm, Synnöve, Savic, Radojka M, Karlsson, Mats O, Juliusson, Gunnar, Liliemark, Jan, Albertioni, Freidoun
Publicado em 2005

Standard Error of Empirical Bayes Estimate in NONMEM® VI

Por Kang, Dongwoo, Bae, Kyun-Seop, Houk, Brett E., Savic, Radojka M., Karlsson, Mats O.
Publicado em 2012

Population Pharmacokinetics of Rifapentine and Desacetyl Rifapentine in Healthy Volunteers: Nonlinearities in Clearance and Bioavailability

Por Savic, Radojka M., Lu, Yanhui, Bliven-Sizemore, Erin, Weiner, Marc, Nuermberger, Eric, Burman, William, Dorman, Susan E., Dooley, Kelly E.
Publicado em 2014

Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption

Por Wilkins, Justin J., Savic, Radojka M., Karlsson, Mats O., Langdon, Grant, McIlleron, Helen, Pillai, Goonaseelan, Smith, Peter J., Simonsson, Ulrika S. H.
Publicado em 2008

The pharmacokinetics of oxypurinol in people with gout

Por Stocker, Sophie L, McLachlan, Andrew J, Savic, Radojka M, Kirkpatrick, Carl M, Graham, Garry G, Williams, Kenneth M, Day, Richard O
Publicado em 2012

Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients

Por Savic, Radojka M., Barrail-Tran, Aurélie, Duval, Xavier, Nembot, George, Panhard, Xavière, Descamps, Diane, Verstuyft, Céline, Vrijens, Bernard, Taburet, Anne-Marie, Goujard, Cécile, Mentré, France
Publicado em 2012

Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV‐Coinfected Children in India: Recommendations for Dose Modifications

Por Guiastrennec, Benjamin, Ramachandran, Geetha, Karlsson, Mats O., Kumar, A.K. Hemanth, Bhavani, Perumal Kannabiran, Gangadevi, N. Poorana, Swaminathan, Soumya, Gupta, Amita, Dooley, Kelly E., Savic, Radojka M.
Publicado no Clin Pharmacol Ther (2018)

Predicting Optimal Dihydroartemisinin-Piperaquine Regimens to Prevent Malaria During Pregnancy for Human Immunodeficiency Virus–Infected Women Receiving Efavirenz

Por Wallender, Erika, Vucicevic, Katarina, Jagannathan, Prasanna, Huang, Liusheng, Natureeba, Paul, Kakuru, Abel, Muhindo, Mary, Nakalembe, Mirium, Havlir, Diane, Kamya, Moses, Aweeka, Francesca, Dorsey, Grant, Rosenthal, Philip J, Savic, Radojka M
Publicado no J Infect Dis (2018)

Pediatric tuberculous meningitis: model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children

Por Savic, Radojka M., Ruslami, Rovina, Hibma, Jennifer E., Hesseling, Anneke, Ramachandran, Geetha, Ganiem, A. Rizal, Swaminathan, Soumya, McIlleron, Helen, Gupta, Amita, Thakur, Kiran, van Crevel, Reinout, Aarnoutse, Rob, Dooley, Kelly E.
Publicado no Clin Pharmacol Ther (2015)

Novel Dosing Strategies Increase Exposures of the Potent Antituberculosis Drug Rifapentine but Are Poorly Tolerated in Healthy Volunteers

Por Dooley, Kelly E., Savic, Radojka M., Park, Jeong-Gun, Cramer, Yoninah, Hafner, Richard, Hogg, Evelyn, Janik, Jennifer, Marzinke, Mark A., Patterson, Kristine, Benson, Constance A., Hovind, Laura, Dorman, Susan E., Haas, David W.
Publicado no Antimicrob Agents Chemother (2015)

A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on Metformin

Por Goswami, Srijib, Yee, Sook Wah, Xu, Fei, Sridhar, Sneha B., Mosley, Jonathan JD, Takahashi, Atsushi, Kubo, Michiaki, Maeda, Shiro, Davis, Robert L., Roden, Dan M., Hedderson, Monique M., Giacomini, Kathleen M., Savic, Radojka M.
Publicado no Clin Pharmacol Ther (2016)

The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin

Por Hibma, Jennifer E., Zur, Arik A., Castro, Richard A., Wittwer, Matthias B., Keizer, Ron J., Yee, Sook Wah, Goswami, Srijib, Stocker, Sophie L., Zhang, Xuexiang, Huang, Yong, Brett, Claire M., Savic, Radojka M., Giacomini, Kathleen M.
Publicado no Clin Pharmacokinet (2016)

Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data

Por Rifat, Dalin, Prideaux, Brendan, Savic, Radojka M., Urbanowski, Michael E., Parsons, Teresa L., Luna, Brian, Marzinke, Mark A., Ordonez, Alvaro A., DeMarco, Vincent P., Jain, Sanjay K., Dartois, Veronique, Bishai, William R., Dooley, Kelly E.
Publicado no Sci Transl Med (2018)

Reduced Renal Clearance of Cefotaxime in Asians with a Low-Frequency Polymorphism of OAT3 (SLC22A8)

Por Yee, Sook Wah, Nguyen, Anh Nguyet, Brown, Chaline, Savic, Radojka M., Zhang, Youcai, Castro, Richard A., Cropp, Cheryl D., Choi, Ji Ha, Singh, Diment, Tahara, Harunobu, Stocker, Sophie L., Huang, Yong, Brett, Claire M., Giacomini, Kathleen M.
Publicado em 2013

Effect of Weight and Maturation on Busulfan Clearance in Infants and Small Children Undergoing Hematopoietic Cell Transplantation

Por Savic, Radojka M, Cowan, Morton J., Dvorak, Christopher C., Pai, Sung-Yun, Pereira, Luis, Bartelink, Imke H., Boelens, Jaap. J., Bredius, Robbert G.M., Wynn, Rob F., Cuvelier, Geoff D.E., Shaw, Peter J., Slatter, Mary A., Long-Boyle, Janel
Publicado em 2013